Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Single-Cell RNA Sequencing Reveals Pericytes Acquire a Fibrotic Phenotype and Promote Mesenteric Adipose Tissue Fibrosis in Crohn's Disease.

Zhang D., Yu A., He M., Zhou Q., Sun S., Bai L.

Prospective Study on Autoimmune Research, published in J Inflamm Res (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
J Inflamm Res (2025)
Country
New Zealand
Reported sample size
—
Source database
PubMed
PMID
40831515
PMCID
PMC12360394
DOI
10.2147/JIR.S528171
Citations
2

Abstract (original English)

Purpose Creeping fat (CF) in Crohn's disease (CD) is characterized by hyperplastic mesenteric adipose tissue (MAT) encasing fibrotic intestinal segments, marked by significant extracellular matrix (ECM) remodeling and fibrosis. Pericytes have multipotent differentiation potential, can adopt a fibrotic phenotype, and contribute to pathological ECM deposition. However, the cellular mechanisms underlying CF fibrosis remain unclear. This study aimed to elucidate the cellular origins of CF fibrosis and the involvement of pericytes. Patients and methods Histopathological analyses evaluated fibrosis in MAT samples and its correlation with adjacent muscularis propria thickening. Transcriptomic datasets and immunofluorescence confirmed fibrosis-related gene expression differences in MAT. Single-cell RNA sequencing (scRNA-seq) was analyzed to evaluate ECM production across cell types and identify pericyte-specific markers. Cell proportion analyses and in vitro experiments quantified vascular endothelial and mural cell populations. CytoTRACE and pseudotime analyses mapped pericyte differentiation trajectories. Primary human MAT pericytes were isolated and stimulated with transforming growth factor-β1 (TGF-β1) to assess fibrotic phenotype transition in vitro. Results Fibrosis was evident in uninvolved MAT from CD patients (CD-MAT) and CF, with fibrosis severity in CF correlating positively

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research